Sotera Health will release third-quarter financial results on November 4, followed by a conference call at 9:00 a.m. EDT.
Quiver AI Summary
Sotera Health Company, a key provider of sterilization solutions and lab testing for the healthcare sector, announced that it will release its financial results for the third quarter on November 4, 2025, before the market opens. Following the release, the management will hold a conference call at 9:00 a.m. EDT to discuss the results and operational updates. Participants can join the call by dialing specific numbers or access a live webcast via the company’s website. A replay of the call will be offered later that day. Sotera Health operates through its subsidiary brands and is dedicated to its mission of safeguarding global health.
Potential Positives
- Sotera Health Company is scheduled to release its third-quarter financial results on November 4, 2025, indicating transparency and communication with stakeholders.
- The company will host a conference call to discuss the financial results and operating highlights, providing an opportunity for direct engagement with investors.
- The availability of a live webcast and replay for the conference call enhances accessibility for investors and analysts.
Potential Negatives
- Announcement of financial results before the market opens could indicate a potential concern about the performance, as companies typically choose specific times to manage investor sentiment.
- The mention of Ethylene Oxide suggests ongoing regulatory scrutiny or health-related issues that may impact the company's reputation and operations.
- The need to host a conference call to discuss results implies there might be significant information that requires clarification, which could raise investor apprehensions.
FAQ
When will Sotera Health release its third-quarter financial results?
Sotera Health will release its financial results for the third quarter on November 4, 2025, before market opens.
What time is the conference call to discuss Sotera Health's financial results?
The conference call will take place at 9:00 a.m. Eastern Daylight Time on November 4, 2025.
How can I access the live webcast of the conference call?
The live webcast can be accessed via the Investor Relations section of Sotera Health's website or directly through the provided link.
What is the purpose of Sotera Health's conference call?
The conference call aims to discuss the Company's financial results and operational highlights for the third quarter.
Where can I find updates relevant to Sotera Health investors?
Updates for investors can be found in the Investor Relations section of Sotera Health's website.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$SHC Insider Trading Activity
$SHC insiders have traded $SHC stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $SHC stock by insiders over the last 6 months:
- PINCUS & CO. WARBURG has made 0 purchases and 2 sales selling 24,000,000 shares for an estimated $362,664,000.
- INVESTMENT XI LLC GTCR sold 8,000,000 shares for an estimated $120,888,000
- MICHAEL P RUTZ (President of Sterigenics) sold 126,611 shares for an estimated $2,074,305
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$SHC Hedge Fund Activity
We have seen 146 institutional investors add shares of $SHC stock to their portfolio, and 76 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- TPG GP A, LLC removed 6,786,110 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $75,461,543
- SCULPTOR CAPITAL LP added 2,462,489 shares (+27.2%) to their portfolio in Q2 2025, for an estimated $27,382,877
- ARROWMARK COLORADO HOLDINGS LLC removed 1,867,829 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $20,770,258
- POINT72 (DIFC) LTD added 1,136,326 shares (+192.6%) to their portfolio in Q2 2025, for an estimated $12,635,945
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC removed 1,101,604 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $12,249,836
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 1,007,963 shares (+12.5%) to their portfolio in Q2 2025, for an estimated $11,208,548
- KHROM CAPITAL MANAGEMENT LLC added 988,801 shares (+174.1%) to their portfolio in Q2 2025, for an estimated $10,995,467
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$SHC Analyst Ratings
Wall Street analysts have issued reports on $SHC in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Overweight" rating on 10/02/2025
- Goldman Sachs issued a "Buy" rating on 05/05/2025
To track analyst ratings and price targets for $SHC, check out Quiver Quantitative's $SHC forecast page.
$SHC Price Targets
Multiple analysts have issued price targets for $SHC recently. We have seen 2 analysts offer price targets for $SHC in the last 6 months, with a median target of $18.0.
Here are some recent targets:
- Luke Sergott from Barclays set a target price of $19.0 on 10/02/2025
- Matthew Sykes from Goldman Sachs set a target price of $17.0 on 05/05/2025
Full Release
CLEVELAND, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced it will release its financial results for the third-quarter ended September 30, 2025 before the market opens on Tuesday, November 4, 2025. Following the release, management will host a conference call at 9:00 a.m. Eastern Daylight Time to discuss the Company’s financial results and operating highlights.
To participate in the live call, please dial 1-844-481-2916 (toll-free in the United States), or 1-412-317-0709 if dialing-in from other locations. A live webcast of the conference call will be accessible at this link or via the Investor Relations section of the Company’s website at Presentation & Events | Sotera Health , along with the accompanying materials. A replay of the webcast will be available on the Company’s website later in the day on November 4 th .
About Sotera Health
Sotera Health Company is a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry. Sotera Health goes to market through three businesses – Sterigenics
®
, Nordion
®
and Nelson Labs
®
. Sotera Health is committed to its mission, Safeguarding Global Health
®
.
Updates can be found from time to time on recent developments in matters relevant to investors on the Investor Relations section of the Company’s website at Investor Relations | Sotera Health . For developments related to Ethylene Oxide, updates can be found at Ethylene Oxide | Sotera Health .
Source: Sotera Health Company
Contacts
Jason Peterson
Vice President, Investor Relations & Treasurer
[email protected]
Kristin Gibbs
Chief Marketing Officer, Sotera Health
[email protected]
